Found 21 matching trials
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC N/A The purpose of this study is to evaluate the safety and efficacy of hepatic...
Show More Status
Active Not Recruiting
Location
The first hospital of China medical university
Learn More & Join Trial
Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma PHASE2 To evaluate the efficacy and safety of Donafenib plus Sintilimab in combina...
Show More Status
Active Not Recruiting
Location
Nanfang Hospital, Southern Medical University
Learn More & Join Trial
Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma PHASE2 The investigators design a phase IIB clinical study to explore the efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
Donafenib Plus Sintilimab for Advanced HCC PHASE2 This study will evaluate the efficacy and safety of donafenib combined with...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer PHASE2 This study is a single-arm intervention study. Locally advanced differentia...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma PHASE2 This is a single-arm exploratory clinical study to evaluate the efficacy an...
Show More Location
Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Learn More & Join Trial
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion PHASE4 A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
HAIC Combined With Donafenib and Sintilimab for Unresectable ICC PHASE2 To evaluate the safety and tolerability of HAIC combined with donafenib and...
Show More Location
Zhongda Hospital, Southeast University
Learn More & Join Trial
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma N/A The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial